DYN
Price
$11.11
Change
+$0.33 (+3.06%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.26B
6 days until earnings call
IGMS
Price
$1.40
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
87.27M
14 days until earnings call
Ad is loading...

DYN vs IGMS

Header iconDYN vs IGMS Comparison
Open Charts DYN vs IGMSBanner chart's image
Dyne Therapeutics
Price$11.11
Change+$0.33 (+3.06%)
Volume$39.79K
Capitalization1.26B
IGM Biosciences
Price$1.40
Change-$0.00 (-0.00%)
Volume$4.52K
Capitalization87.27M
DYN vs IGMS Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. IGMS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and IGMS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (DYN: $10.78 vs. IGMS: $1.39)
Brand notoriety: DYN and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 198% vs. IGMS: 140%
Market capitalization -- DYN: $1.13B vs. IGMS: $87.27M
DYN [@Biotechnology] is valued at $1.13B. IGMS’s [@Biotechnology] market capitalization is $87.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, IGMS is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while IGMS’s TA Score has 3 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • IGMS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than IGMS.

Price Growth

DYN (@Biotechnology) experienced а +37.68% price change this week, while IGMS (@Biotechnology) price change was +16.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.26B) has a higher market cap than IGMS($87.3M). DYN YTD gains are higher at: -54.244 vs. IGMS (-77.250). IGMS has higher annual earnings (EBITDA): -199.47M vs. DYN (-342.21M). DYN has more cash in the bank: 642M vs. IGMS (184M). DYN has less debt than IGMS: DYN (24M) vs IGMS (45.2M). IGMS has higher revenues than DYN: IGMS (2.68M) vs DYN (0).
DYNIGMSDYN / IGMS
Capitalization1.26B87.3M1,446%
EBITDA-342.21M-199.47M172%
Gain YTD-54.244-77.25070%
P/E RatioN/AN/A-
Revenue02.68M-
Total Cash642M184M349%
Total Debt24M45.2M53%
TECHNICAL ANALYSIS
Technical Analysis
DYNIGMS
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX39.26N/A
N/A
PGIM Quant Solutions Large-Cap Index A
FIFRX120.31N/A
N/A
Franklin Growth R6
MGLKX15.65N/A
N/A
MFS Global Real Estate R2
MLNCX20.80N/A
N/A
Morgan Stanley Instl Glbl Concntr C
WSACX24.79N/A
N/A
Wellington Shields All-Cap Instl

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+8.78%
CRNX - DYN
50%
Loosely correlated
+3.55%
ROIV - DYN
48%
Loosely correlated
+2.98%
INZY - DYN
47%
Loosely correlated
-4.84%
RNA - DYN
47%
Loosely correlated
+4.18%
ERAS - DYN
47%
Loosely correlated
+2.90%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with INZY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-4.79%
INZY - IGMS
53%
Loosely correlated
-4.84%
MRSN - IGMS
51%
Loosely correlated
+2.39%
CRNX - IGMS
47%
Loosely correlated
+3.55%
DYN - IGMS
45%
Loosely correlated
+8.78%
NTLA - IGMS
43%
Loosely correlated
-2.65%
More